itanoxone has been researched along with aspirin in 1 studies
*Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) [MeSH]
*Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Gaetano, G; Delhon, A; Lauressergues, H; Livio, M; Maynadier, B; Palmier, C; Villa, S | 1 |
1 other study(ies) available for itanoxone and aspirin
Article | Year |
---|---|
Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in rats.
Topics: Animals; Aspirin; Biphenyl Compounds; Blood Platelets; Blood Vessels; Butyrophenones; Dose-Response Relationship, Drug; Hypolipidemic Agents; Male; Malondialdehyde; Prostaglandins; Rats; Thromboxane B2; Uricosuric Agents | 1981 |